Monsanto and ToolGen Announce Global Licensing Agreement on CRISPR Platform, Underscore the Benefits of … – Business Wire (press release)
|
Monsanto and ToolGen Announce Global Licensing Agreement on CRISPR Platform, Underscore the Benefits of …
Business Wire (press release) “We are excited to bring ToolGen's CRISPR platform on board at Monsanto, and are continuing to bolster and diversify our capabilities in this field of research,” said Tom Adams, Ph.D., vice president of biotechnology for Monsanto. “As a company we … |
